BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Feb 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-02-24

Reporting Person: Mueller Brian (VP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-24	Common Stock	M	5000	$11.74	Acquired	13300	Direct
2012-02-24	Common Stock	S	5000	$35.065	Disposed	8300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-24	Stock Option (right to buy)	$11.74	M	5000	Disposed	2016-01-06	Common Stock (5000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $35.01 to $35.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vests 6/48ths on July 6, 2006 and 1/48th on the 6th of each month thereafter.